EcoDrugPlus

Tubulin Alpha Chain-Like

Ensembl ID : ENSAOCG00000012883
Gene Symbol: LOC111572891
3 Cross references
158 Possible Orthologues:

Tubulin Alpha-1a Chain-Like

Ensembl ID : ENSAOCG00000009186
Gene Symbol: LOC111584480
2 Cross references
142 Possible Orthologues:

Tubulin Alpha-1a Chain-Like

Ensembl ID : ENSAOCG00000010597
Gene Symbol: LOC111584421
2 Cross references
143 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSAOCG00000008641
Gene Symbol: LOC111581946
2 Cross references
144 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSAOCG00000008190
Gene Symbol: LOC111569453
3 Cross references
253 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSAOCG00000013258
Gene Symbol: LOC111565388
2 Cross references
244 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSAOCG00000002022
Gene Symbol: LOC111568690
3 Cross references
301 Possible Orthologues:

Tubulin Beta-4b Chain

Ensembl ID : ENSAOCG00000001080
Gene Symbol: LOC111585474
2 Cross references
182 Possible Orthologues:

Tubulin Beta-6 Chain-Like

Ensembl ID : ENSAOCG00000007034
Gene Symbol: LOC111585085
2 Cross references
184 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSAOCG00000017061
Gene Symbol: LOC111571060
3 Cross references
189 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSAOCG00000015512
Gene Symbol: TYR
3 Cross references
196 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSAOCG00000001583
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).